Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-1238
    Keywords: Key wordsK. pneumoniae ; Bacteremia ; Mechanical ventilation ; Blood gases ; Animal ; Rat
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective: To determine the effect of peak inspiratory pressure (PIP) and positive end-expiratory pressure (PEEP) on the development of bacteremia with Klebsiella pneumoniae after mechanical ventilation of intratracheally inoculated rats. Design: Prospective, randomized, animal study. Setting: Experimental intensive care unit of a University. Subjects: Eighty male Sprague Dawley rats. Interventions: Intratracheal inoculation with 100 μl of saline containing 3.5–5.0 × 105 colony forming units (CFUs) K. pneumoniae/ml. Pressure-controlled ventilation (frequency 30 bpm; I/E ratio = 1 : 2; FIO2 = 1.0) for 180 min at the following settings (PIP/PEEP in cmH2O): 13/3 (n = 16); 13/0 (n = 16); 30/10 (n = 16) and 30/0 (n = 16), starting 22 h after inoculation. Arterial blood samples were obtained and cultured before and 180 min after mechanical ventilation and immediately before sacrifice in two groups of non-ventilated control animals (n = 8 per group). After sacrifice, the lungs were homogenized to determine the number of CFUs K. pneumoniae. Measurements and results: The number of CFUs recovered from the lungs was comparable in all experimental groups. After 180 min, 11 animals had positive blood cultures for K. pneumoniae in group 30/0, whereas only 2, 0 and 2 animals were positive in 13/3, 13/0 and 30/10, respectively (p 〈 0.05 group 30/0 versus all other groups). Conclusions: These data show that 3 h of mechanical ventilation with a PIP of 30 cmH2O without PEEP in rats promotes bacteremia with K. pneumoniae. The use of 10 cmH2O PEEP at such PIP reduces ventilation-induced K. pneumoniae bacteremia.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1076
    Keywords: Key words Ciprofloxacin ; Paediatric ; Preterm neonates ; Pharmacology ; Side-effects
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract We report the use of ciprofloxacin in a preterm boy suffering from an invasive multiple resistant Enterobacter cloacae infection. The treatment was effective, after other antibiotics failed, and no adverse effects were observed during 3 years of follow up. The literature on compassionate ciprofloxacin use in 28 preterm or low birth weight infants is reviewed. Ciprofloxacin has been used to treat neonatal pneumonia, meningitis and septicaemia and was effective in all cases. Side-effects were limited to dental dyschromia and one observation on the emergence of resistance. Pharmacokinetics of ciprofloxacin were studied in seven preterm infants; iv doses ranging from 4 to 40 mg/kg per day revealed adequate serum peak concentrations (0.98–5.7 mg/l) but trough-peak ratios were high (median ratio: 32%), suggesting slower elimination in preterm infants as compared to older children. CSF concentrations were 0.10–1.45 mg/l. Conclusion Ciprofloxacin treatment of preterm or low birth weight infants may be effective and without severe side effects in infections with bacteria resistant to other antibiotics
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1238
    Keywords: Key words Bacterial peritonitis ; Intra-abdominal infection ; ICU ; Pharmacokinetics ; Bioavailability ; Ciprofloxacin
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background: Few data are available on the pharmacokinetics of multiple enteral dosing of ciprofloxacin in critically ill intensive care patients and none for those with severe gram-negative intra-abdominal infections (GNIAI). Objective: To determine the bioavailability of enteral ciprofloxacin in tube-fed intensive care patients with severe GNIAI. Design: A randomized crossover study. Setting: University-based medical center. Patients: 5 critically ill intensive care patients with GNIAI and an estimated creatinine clearance 〉 25 ml/min who received continuous tube feeding. Interventions: Multiple doses of enteral 750 mg b. i. d. versus 400 mg b. i. d. i. v. ciprofloxacin. Measurements: The calculated 12-h area under the serum concentration versus time curve after 750 mg b. i. d. enteral dosing was equivalent to that after 400 mg b. i. d. i. v. The mean bioavailability of enteral dosing was 53.1 % [95 % confidence interval (CI) 43.5–62.8]. In seven additional patients, the mean serum steady-state concentration at 2 h after enteral administration was 3.9 μg/ml (95 % CI 1.9–5.9), not significantly different from that found in the crossover study (p = 0.4). Conclusions: In tube-fed intensive care patients with severe GNIAI, the bioavailability of enteral ciprofloxacin is adequate.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical microbiology & infectious diseases 10 (1991), S. 785-786 
    ISSN: 1435-4373
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical microbiology & infectious diseases 12 (1993), S. S58 
    ISSN: 1435-4373
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Optimal use of a drug depends on rational dosing and subsequent therapeutic drug monitoring for effectiveness and toxicity. Drug monitoring is not relevant for all drugs, but is indicated in the case of drugs which have a narrow therapeutic range or show a large inter-individual variation. If the response is not satisfactory or toxic side effects are observed, the regimen has to be adjusted or another drug used. Methods have been developed to establish rational dosing schedules for the individual patient. In previous methods, the patient's specific data such as age, length, weight and serum creatinine are integrated with population pharmacokinetic parameters for a drug. This approach is subject to an appreciable margin of error, particularly in patients whose physiology is far from normal. Therapeutic drug monitoring via blood level determination makes it possible to evaluate the patient's individual pharmacokinetic parameters on which a rational dosage regimen can be based.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...